SCHEMBL659953

SCHEMBL659953

Nc1nccc2cc(-c3cccc4cnncc34)oc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 2/20 0.41
PDE4D Q08499 2/20 0.39
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
F12 P00748 1/20 0.37
PLAU P00749 1/20 0.37
NCF1 P14598 1/20 0.37
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
BACE1 P56817 1/20 0.37
NPC1 O15118 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
MAP3K7 O43318 3/20 0.33
TAB1 Q15750 3/20 0.33
MAP4K4 O95819 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660235 0.86 LMNA (0.44) TLR8PDE4DRAB9AALDH1A1KDM4E
SCHEMBL657881 0.80 MAP3K7 (0.38) PDE4DMAP3K7TAB1
SCHEMBL657741 0.77 MAP3K7 (0.45) TLR8PDE4DRAB9AALDH1A1KDM4E
SCHEMBL660290 0.77 MAP3K7 (0.48) TLR8MAP3K7TAB1
SCHEMBL659270 0.75 MAP3K7 (0.47) TLR8PDE4DRAB9AALDH1A1KDM4E
SCHEMBL659026 0.71 RAB9A (0.58) TLR8RAB9AALDH1A1KDM4EF12
SCHEMBL659522 0.70 QPCT (0.39) TLR8RAB9AALDH1A1KDM4EMAP3K7
SCHEMBL12444602 0.70 MAP3K7 (0.36) MAP3K7TAB1
SCHEMBL29421593 0.69 NOS3 (0.54) TLR8F12PLAUNCF1NOS3
SCHEMBL664646 0.68 MAP3K7 (0.64) TLR8MAP3K7TAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 TLR8 2644/4885PDE4D 2720/4885RAB9A 1727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.